- Loyola to be the First Chicago Center to Produce CAR T-Cells
As Loyola participates in CAR T-cell clinical trials, the T cells collected will be sent to Loyola's clean lab to be modified to target and fight cancer cells. No other center in Chicago is able to modify these T cells in-house. This could create less toxic and less expensive T cells for leukemia and lymphoma patients.
- Cancer Center Welcomes New Leadership and Pursuit of NCI Designation
Loyola welcomes William Small, Jr., MD, as new director of the Cardinal Bernardin Cancer Center. Among other goals, Dr. Small plans to continue our pursuit of National Cancer Institute (NCI) designation for the center.
- New Breast Cancer Treatment that Reduces Side Effects to be Offered
A new breast cancer radiation therapy that shortens the treatment times by three weeks, while reducing side effects, will now be available for select breast cancer patients at Loyola Medicine at Palos Health South Campus.
- Landmark Study Finds More Breast Cancer Patients Can Safely Avoid Chemotherapy
Loyola Medicine oncologist Kathy Albain, MD, is among the main co-authors of a study that will enable most patients with the most common type of early breast cancer to safely forgo chemotherapy.
Find a Doctor
Our Cancer Care Team
Your dedicated Loyola Medicine team may include (from left) Raymond Wynn, MD; Muaiad Kittaneh, MD; and Hanh Mai, DO.
"...they were going to go right to the tumor which would kill the cancer but keep everything else intact, not damage the healthy tissue." - Donna Valente, Loyola patient